Featured projects (1)
Exploration of safety, tolerability and clinical efficacy of solnatide investigative medicinal product (solnatide IMP) in patients infected with the 2019 new Cornoavirus. SOLNATIDE will clinically test peptide-based products targeting life-threatening pulmonary diseases (such as oedematous respiratory failure, acute lung injury). APEPTICO’s lead-compound solnatide IMP has been designed for the therapeutic treatment of patients with Acute Respiratory Distress Syndrome (ARDS) and various forms of PPO.
No research from this lab has been added yet.